Immune response as a biomarker for cancer detection and a lot more

被引：82

作者：

Finn, OJ ^{[1
]}

机构：

[1] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15260 USA

[2] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 353卷 / 12期

关键词：

D O I：

10.1056/NEJMe058157

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1288 / 1290

页数：3

共 19 条

[1] PSA testing: what is the use? [J].

Crawford, ED .

LANCET, 2005, 365 (9469) :1447-1449

[2] Early identification of individuals with prostate cancer in negative biopsies [J].

Dhir, R ;

Vietmeier, B ;

Arlotti, J ;

Acquafondata, M ;

Landsittel, D ;

Masterson, R ;

Getzenberg, RH .

JOURNAL OF UROLOGY, 2004, 171 (04) :1419-1423

[3]

Fan TWM, 2004, CURR OPIN MOL THER, V6, P584

[4] Glycosylation defining cancer malignancy: New wine in an old bottle [J].

Hakomori, S .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (16) :10231-10233

[5] Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells [J].

Kao, H ;

Marto, JA ;

Hoffman, TK ;

Shabanowitz, J ;

Finkelstein, SD ;

Whiteside, TL ;

Hunt, DF ;

Finn, OJ .

JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (09) :1313-1323

[6]

Koziol JA, 2003, CLIN CANCER RES, V9, P5120

[7] Immunomic analysis of human sarcoma [J].

Lee, SY ;

Obata, Y ;

Yoshida, M ;

Stockert, E ;

Williamson, B ;

Jungbluth, AA ;

Chen, YT ;

Old, LJ ;

Scanlan, MJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (05) :2651-2656

[8] p53 autoantibodies predict subsequent development of cancer [J].

Li, YL ;

Karjalainen, A ;

Koskinen, H ;

Hemminki, K ;

Vainio, H ;

Shnaidman, M ;

Ying, ZL ;

Pukkala, E ;

Brandt-Rauf, PW .

INTERNATIONAL JOURNAL OF CANCER, 2005, 114 (01) :157-160

[9] Fingerprinting the circulating repertoire of antibodies from cancer patients [J].

Mintz, PJ ;

Kim, J ;

Do, KA ;

Wang, XM ;

Zinner, RG ;

Cristofanilli, M ;

Arap, MA ;

Hong, WK ;

Troncoso, P ;

Logothetis, CJ ;

Pasqualini, R ;

Arap, W .

NATURE BIOTECHNOLOGY, 2003, 21 (01) :57-63

[10] Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml [J].

Ornstein, DK ;

Rayford, W ;

Fusaro, VA ;

Conrads, TP ;

Ross, SJ ;

Hitt, BA ;

Wiggins, WW ;

Veenstra, TD ;

Liotta, LA ;

Petricoin, EF .

JOURNAL OF UROLOGY, 2004, 172 (04) :1302-1305

← 1 2 →